Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 67,861 - 67,880 results of 102,972 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( e ((fold decrease) OR (point decrease)) ))', query time: 1.76s Refine Results
  1. 67861
    Comparison of 1D and 3D reservoir heat transport models and temperature effects on mass transport

    Comparison of 1D and 3D reservoir heat transport models and temperature effects on mass transport by Bruna Arcie Polli (10356390)

    Published 2021
    Save to List
    Saved in:
  2. 67862
    CFD simulation of cannabidiol delivery through microneedle patches

    CFD simulation of cannabidiol delivery through microneedle patches by Liqun Shi (8309856)

    Published 2024
    Save to List
    Saved in:
  3. 67863
    Dirt on photovoltaic modules and efficient energy generation in the Brazilian semiarid

    Dirt on photovoltaic modules and efficient energy generation in the Brazilian semiarid by Tiago L. S. de Souza (12820142)

    Published 2022
    Save to List
    Saved in:
  4. 67864
    BIOCHEMICAL AND PIGMENT ANALYSIS ON PHYCOREMEDIATED MICROALGAL BIOMASS

    BIOCHEMICAL AND PIGMENT ANALYSIS ON PHYCOREMEDIATED MICROALGAL BIOMASS by G. k. Saravanan (515483)

    Published 2014
    Save to List
    Saved in:
  5. 67865
    Temperature influence on mobility and charge density model of photovoltaic cells

    Temperature influence on mobility and charge density model of photovoltaic cells by J.S.T. Souza (6380096)

    Published 2019
    Save to List
    Saved in:
  6. 67866
    Supplementary Material for: Cerebral Hemodynamic Failure Presenting as Limb-Shaking Transient Ischemic Attacks

    Supplementary Material for: Cerebral Hemodynamic Failure Presenting as Limb-Shaking Transient Ischemic Attacks by Nedelmann M. (4127125)

    Published 2011
    Save to List
    Saved in:
  7. 67867
    Unexpected transient phenomena in positive lightning

    Unexpected transient phenomena in positive lightning by Ziqin Ding (8470035)

    Published 2022
    Save to List
    Saved in:
  8. 67868
    Rhinorrhea-free days up to day 10.

    Rhinorrhea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  9. 67869
    Vomit-free days up to day 10.

    Vomit-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  10. 67870
    Table_1_Impact of the COVID-19 Lockdown on Air Quality and Resulting Public Health Benefits in the Mexico City Metropolitan Area.DOCX

    Table_1_Impact of the COVID-19 Lockdown on Air Quality and Resulting Public Health Benefits in the Mexico City Metropolitan Area.DOCX by Iván Y. Hernández-Paniagua (10430552)

    Published 2021
    “…SO<sub>2</sub> decreased only during Phase 3 in a near-road environment. …”
    Save to List
    Saved in:
  11. 67871
    Symptoms free-days up to day 10.

    Symptoms free-days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  12. 67872
    Respiratory symptoms-free days up to day 10.

    Respiratory symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  13. 67873
    Other symptoms-free days up to day 10.

    Other symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  14. 67874
    Diarrhea-free days up to day 10.

    Diarrhea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  15. 67875
    Gastrointestinal symptoms-free days up to day 10.

    Gastrointestinal symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  16. 67876
    Nausea-free days up to day 10.

    Nausea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  17. 67877
    Flow of patients in Halos trial.

    Flow of patients in Halos trial. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  18. 67878
    Cough-free days up to day 10.

    Cough-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  19. 67879
    Dyspnea-free days up to day 10.

    Dyspnea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
    Save to List
    Saved in:
  20. 67880
    <i>ITP</i> regulates feeding.

    <i>ITP</i> regulates feeding. by Martina Gáliková (3274566)

    Published 2018
    “…(D) Schematic drawing of the capillary feeding system, which measures the total volume of food eaten during a given period of time. (E) Over-expression of <i>ITP</i> decreases food intake. …”
    Save to List
    Saved in:

Search Tools: